Sudden death in patients with implantable cardioverter defibrillators: The importance of post-shock electromechanical dissociation

Journal of the American College of Cardiology

Volumn 39, Issue 8, 2002, Pages 1323-1328

  Mitchell, L Brent ^a,f   Pineda, Edgar A ^b   Titus, Jack L ^c   Bartosch, Paulette M ^d   Benditt, David G ^e  

^a UNIVERSITY OF CALGARY   (Canada)

^b Cardiac Surgical Associates Florida   (United States)

^c St Paul   (United States)

^d MEDTRONIC INC   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f FOOTHILLS HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; DEFIBRILLATOR; ELECTROSTIMULATION; FEMALE; HEART ELECTROPHYSIOLOGY; HEART PACING; HEART VENTRICLE FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SUDDEN DEATH;

AGED; AGED, 80 AND OVER; CANADA; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; STROKE VOLUME; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 0037123144     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(02)01784-9     Document Type: Article

References (59)

1. Prehospital ventricular fibrillation: Prognosis and follow-up course
2. Resuscitation from out-of-hospital ventricular fibrillation: 4 years follow-up
3. Pharmacological therapy
4. Canadian Implantable Defibrillator Study (CIDS): A randomized trial of implantable cardioverter defibrillator against amiodarone
5. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH)
6. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal sustained ventricular tachyarrhythmias
7. Mortality in patients with implanted automatic defibrillators
8. Clinical experience, complications, and survival in 70 patients with the automatic implantable cardioverter/defibrillator
9. The automatic implantable cardioverter-defibrillator: Efficacy, complications, and device failures
10. The automatic implantable cardioverter-defibrillator: Efficacy, complications and survival in patients with malignant ventricular arrhythmias
11. Mechanism of death in patients with the automatic implantable cardioverter defibrillator
12. Survival of patients with the automatic implantable cardioverter defibrillator
13. Implantable defibrillation: Eight years clinical experience
14. Actuarial incidence and pattern of occurrence of shocks following implantation of the automatic implantable cardioverter defibrillator
15. Clinical experience in seventy-seven patients with the automatic implantable cardioverter defibrillator
16. Time to first shock and clinical outcome in patients receiving an automatic implantable cardioverter-defibrillator
17. Long-term outcome with the automatic implantable cardioverter-defibrillator
18. Efficacy of the automatic implantable cardioverter-defibrillator in prolonging survival in patients with severe underlying cardiac disease
19. Initial clinical experience with the pacemaker-cardioverterdefibrillator
20. Survival in patients with depressed left ventricular function treated by implantable cardioverter defibrillator
21. Reduction in defibrillator shocks with an implantable device combining antitachycardia pacing and shock therapy
22. Six-year clinical experience with the automatic implantable cardioverter defibrillator
23. Role of implantable cardioverter defibrillator therapy in the management of high-risk patients
24. Clinical experience with a tiered-therapy, multiprogrammable antiarrhythmia device
25. Analysis of deaths in patients with an implantable cardioverter defibrillator
26. Efficacy of automatic multimodal device therapy for ventricular tachyarrythmias as delivered by a new implantable pacing cardioverter-defibrillator: Results of a European multicenter study of 102 implants
27. Infuence of left ventricular function on outcome of patients treated with implantable defibrillators
28. Survival after implantation of the cardioverter defibrillator
29. Long-term multicenter experience with a second-generation implantable pacemaker-defibrillator in patients with malignant ventricular tachyarrhythmias
30. Complications of implantable cardioverter defibrillator therapy: Follow-up of 241 patients
31. Infuence of implantable cardioverter-defibrillators on the long-term prognosis of out-of-hospital cardiac arrest
32. Clinical experience with antitachycardia pacing and improved detection algorithms in a new implantable cardioverter-defibrillator
33. Safety of antitachycardia pacing in patients with implantable cardioverter defibrillators and severely depressed left ventricular function
34. Results of delivered therapy for VT or VF in patients with third-generation implantable cardioverter defibrillators
35. Results of the international study of the implantable pacemaker cardioverter-defibrillator: A comparison of epicardial and endocardial lead systems
36. Classification of death in antiarrhythmia trials
37. Sudden death in patients with implantable cardioverter-defibrillators
38. Exploration of the precision of classifying sudden cardiac death: Implications for the interpretation of clinical trials
39. Cardiac death and stored electrograms in patients with third-generation implantable cardioverter defibrillators
40. Standardized reporting of ICD patient outcome: The report of a North American Society of Pacing and Electrophysiology policy conference
41. Clinical evaluation of the safety of repetitive intraoperative defibrillation threshold testing
42. Influence of the implantable cardioverter/defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation
43. Sudden death in implantable cardioverter-defibrillator recipients: Clinical context, arrhythmic events and device responses
44. A morphologic study of canine hearts subjected to fibrillation, electrical defibrillation and manual compression
45. Acute cardiac damage in dogs given multiple transthoracic shocks with a trapezoidal wave-form defibrillator
46. Therapeutic indices for transchest defibrillator shocks: Effective, damaging, and lethal electrical doses
47. Ultrastructural injury to chick myocardial cells in vitro following "electric countershock"
48. Death and damage caused by multiple direct current shocks: Studies in an animal model
49. Oxidative metabolism and myocardial blood flow changes after transthoracic DC countershock in dogs
50. Pathologic findings related to the lead system and repeated defibrillations in patients with the automatic implantable cardioverter-defibrillator
51. Automatic implantable cardioverter/defibrillator discharges and acute myocardial injury
52. Hemodynamic deterioration during ICD implant: Predictors of high-risk patient
53. Influence of left ventricular function on outcome of patients treated with implantable defibrillators
54. Shock strength for the implantable defibrillator: Can you have too much of a good thing?
55. Cardiac potential and potential gradient fields generated by single, combined, and sequential shocks during ventricular fibrillation
56. Improved defibrillator waveform safety factor with biphasic waveforms
57. The effects of shock energy, propranolol, and verapamil on cardiac damage caused by transthoracic countershock
58. Electrical therapy for pulseless electrical activity
59. Sudden death in patients with implantable cardioverter defibrillators: The importance of cardiac annihilation